News Novartis takes option on NASH drug from Conatus Swiss pharma takes option on FXR agonist emricasan.
News AbbVie takes aim at Gilead and BMS with 8-week hep C treatme... Trial backs patient-friendly regime in tough to treat strain.
Gilead Wales experts back HIV prophlyaxis, ahead of key meetings Cost-effectiveness bodies in Wales and Scotland to decide on Truvada in April.
News Pfizer under investigation over links with charities US authorities probing several other drugmakers amid pricing row.
News Is BMS the next pharma takeover target? Speculation mounting that Pfizer and others could try for $90 bn plus merger
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.